PULMOBIOMED LTD
Company number 12552857 · Monitor this company
The confirmation statement for this company is overdue.
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£1,581,723
Balance sheet as at 2025-04-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-04-09
- Registered office
- Suite 5 Bulman House, Regent Centre, Newcastle Upon Tyne, NE3 3LS
- Postcode
- NE3 3LS
- Capital
- 161 GBP
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-04-30
- Next due by
- 2027-01-31
- Financial year end
- 30 April
Confirmation statement
- Last statement dated
- 2025-06-12
- Next due by
- 2026-06-26 Overdue
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current · 4 resigned
Contact details
- Website
- pulmobiomed.com
Pulmobiomed has developed a best-in-class exhaled breath condensate device, capable of capturing Covid-19 particles in as little as 5 seconds. Pulmobiomed a biotechnology company is working with industry leaders in integrating their diagnostic capabilities into our PBM-Hale device. Pulmobiomed techn
The class of 2020
41%
of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.